Evidence map›Paper›PMID 38806680›Full record

ArticleScientific reports2024

Developing a nomogram based on SEER database for predicting prognosis in choroid plexus tumors.

Zedi Yang, Heng Jiang, Ding He, Sheng Zhang, Lei Huang, Peigeng Gao, Haiyan Huang, Junguo Cao, Zhixin Zhan

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zedi YangDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, China.
Heng JiangDepartment of Neurosurgery, The Second Hospital of Jilin University, Changchun, 130041, China.
Ding HeDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, China.
Sheng ZhangDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, China.
Lei HuangDepartment of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, 130021, China.
Peigeng GaoDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, China.
Haiyan HuangDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, China.
Junguo CaoDepartment of Neurosurgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China. junguo.cao@zju.edu.cn.
Zhixin ZhanDepartment of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021, China. zhanzx@jlu.edu.cn.

Funding

the Doctor of excellence program (DEP), The First Hospital of Jilin University JDYY-DEP-2023014
6 · The paper itself

Abstract

Choroid plexus tumors (CPT) are rare and highly vascularized neoplasms that have three histologically confirmed diagnoses, including choroid plexus papilloma, atypical choroid plexus papilloma, and choroid plexus carcinoma (CPC). This study aimed to determine the epidemiology and survival of patients with CPTs and develop a nomogram to quantify the prognosis of the patients with CPT. Data of 808 patients who were diagnosed as CPT between 2000 and 2020 was obtained from the surveillance, epidemiology, and end results database. Descriptive analysis was used to assess the distribution and tumor-related characteristics of the patients with CPT. Independent prognostic factors for patients with CPT were identified by univariate and multivariate Cox regression analysis. The nomogram was established and evaluated by receiver operating characteristic curve, and decision curve analysis (DCA), calibration curves. The independent prognostic factors for patients with CPT are age, tumor size, surgery, chemotherapy, tumor number, pathologies, and race. For the prognostic nomogram, the area under the curve (AUC) of 60-, 120-, and 180-months were 0.855, 0.869 and 0.857 in the training set and 0.836, 0.864 and 0.922 in the test set. The DCA and calibration curve indicated the good performance of the nomogram. Patients with CPTs can be diagnosed at any age. Among the three histopathological tumors, patients with CPC had the worst prognosis. The nomogram was established to predict the prognosis of patients with CPT, which had satisfactory accuracy, and clinical utility may benefit for clinical decision-making.

Indexed as

Choroid Plexus NeoplasmsNomogramsSEER ProgramAdolescentAdultAgedCarcinomaChildChild, PreschoolFemaleHumansInfantMaleMiddle AgedPrognosisROC CurveChoroid plexus tumorEpidemiologyNomogramPrognosisSEER program

Identifiers

PMID38806680
PMCPMC11133321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.